Home > Riviste > Minerva Ginecologica > Fascicoli precedenti > Minerva Ginecologica 2017 December;69(6) > Minerva Ginecologica 2017 December;69(6):538-47

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA GINECOLOGICA

Rivista di Ostetricia e Ginecologia


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

ORIGINAL ARTICLE  


Minerva Ginecologica 2017 December;69(6):538-47

DOI: 10.23736/S0026-4784.17.04062-X

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Early detection of recurrence or progression disease in patients with ovarian cancer after primary debulking surgery. Correlation between CT findings and CA 125 levels

Michela GIULIANI 1, Benedetta GUI 1 , Anna L. VALENTINI 1, Silvia E. DI GIOVANNI 1, Maura MICCÒ 1, Elena RODOLFINO 1, Matteo FALCIONE 1, Chiara DE WAURE 2, Eleonora PALLUZZI 3, Vanda SALUTARI 3, Giovanni SCAMBIA 3, Riccardo MANFREDI 1

1 Diagnostic Imaging Area, Sacro Cuore Catholic University, Rome, Italy; 2 Department of Hygiene, Sacro Cuore Catholic University, Rome, Italy; 3 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Sacro Cuore Catholic University, Rome, Italy


PDF  


BACKGROUND: There are no standard approaches for follow up in advanced ovarian cancer (AOC) patients; the aim of this study is to evaluate correlation between computed tomography (CT) and CA 125 levels to assess early detection of recurrence or progression disease (PD).
METHODS: We included 76 patients with AOC, who had prior debulking surgery, starting first or second line of chemotherapy and underwent follow-up CT examinations. Evaluation of tumor response to treatment by imaging was assessed using RECIST 1.1. Site of relapse was classified as: abdomen, chest and neck (observed in the upper chest scans).
RESULTS: Change in CA 125 levels was calculated in respect previous evaluation at the end of treatment for each patient. The most suitable cut-offs could be identified in an increase in CA 125 levels >10.5% (sensitivity: 67.9%; specificity: 83.6%; LR+: 4.1; LR-: 0.4) in order to predict PD and in a change of -0.5% in order to exclude PD (sensitivity 83.0%; specificity: 69.6%; LR+: 2.7; LR-: 0.2). Site of relapse was abdomen (58.5%), abdomen and chest (33.9%), chest (3.8%), chest and neck (1.9%), and abdomen, chest and neck (1.9%).
CONCLUSIONS: Increase in CA 125 levels >10.5% could be sufficiently predictive of PD requiring CT examination. Change of -0.5% is sufficiently predictive of absence of PD. Increase <10.5% and >0.5% needs clinical correlation to establish correct timing and extension of CT examination. Attention must be played in reducing number and extent of CT examinations to reduce exposure dose.


KEY WORDS: CA-125 Antigen - Follow-up studies - Ovarian neoplasms - Radiation exposure - Tomography, X-ray computed

inizio pagina

Publication History

Issue published online: October 24, 2017
Article first published online: June 9, 2017
Manuscript accepted: May 24, 2017
Manuscript received: March 21, 2017

Per citare questo articolo

Giuliani M, Gui B, Valentini AL, Di Giovanni SE, Miccò M, Rodolfino E, et al. Early detection of recurrence or progression disease in patients with ovarian cancer after primary debulking surgery. Correlation between CT findings and CA 125 levels. Minerva Ginecol 2017;69:538-47. DOI: 10.23736/S0026-4784.17.04062-X

Corresponding author e-mail

benedetta.gui@policlinicogemelli.it